Workflow
康泰生物股票
icon
Search documents
康泰生物: 2025年第二季度可转换公司债券转股情况公告
Zheng Quan Zhi Xing· 2025-07-02 16:06
Core Points - The company announced the latest conversion price for its convertible bonds is RMB 15.73 per share [1] - The total amount of convertible bonds issued is RMB 2,000 million, with a face value of RMB 100 per bond [2] - As of June 30, 2025, the remaining convertible bonds amount to RMB 1,999,004,300, with 19,990,043 bonds still outstanding [2][3] Convertible Bond Issuance - The company issued 20 million convertible bonds on July 15, 2021, approved by the China Securities Regulatory Commission [1] - The bonds were listed on the Shenzhen Stock Exchange on August 5, 2021, under the name "康泰转2" and code "123119" [2] - The conversion period for the bonds started on January 1, 2022, and will last until the bonds mature [2] Share Capital Changes - The conversion of 650 shares occurred, reducing the number of convertible bonds by 103 [2] - The total share capital before the conversion was 1,116,927,887 shares, which increased to 1,116,928,537 shares after the conversion [3] - The proportion of restricted shares decreased from 20.69% to 19.44%, while unrestricted shares increased from 79.31% to 80.56% [3]